Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer.

Front Genet · 2021 · PMC8548647 · PMID 34721537

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The expression of CLDN10 in T2 gastric cancer patients was associated with OS and PFS (OS p = 0.03; PFS p = 0.027), and the value of HR has a decreasing trend with increasing tumor development.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.